IndraLab

Statements

N-[3-[[5-cyclopropyl-2-[3-(4-morpholinylmethyl)anilino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide inhibits IKBKE. 6 / 6
1 | 5
reach
"The IKKepsilon and TBK1 inhibitor MRT67307 inhibits CYLD phosphorylation independent of IKKepsilon and TBK1."
29755980
reach
"As it was shown previously that MRT67307 can inhibit IKKepsilon and TBK1 at concentrations as low as 1-2 muM, the concentration of 10 muM used may have led to off-target effects."
29755980
reach
"MRT67307 specifically inhibits the IKKepsilon and TBK1 kinases, which are involved in controlling the production of Type1 interferons but also participate in a negative regulatory loop that restricts the extent of activation of the IKK complex [XREF_BIBR] [XREF_BIBR]."
29958295
tas
No evidence text available
reach
"In addition, the MRC PPU International Centre for Kinase Profiling reported in vitro specificity screens for several inhibitors (http://www.kinase-screen.mrc.ac.uk/kinase-inhibitors), showing that MRT67307 not only inhibits IKKepsilon and TBK1 and the AMPK related kinases MARK, MELK and NUAK, but also Mixed Lineage Kinase (MLK) 1 and MLK3, Janus kinase (JAK) 2, and Ca (2+)/calmodulin-dependent protein kinase kinase beta (CamKKbeta)."
29755980
reach
"Blocking TBK1 and IKKepsilon during transduction of NK cells enabled their efficient transduction by VSV-G LVs as judged by YFPexpression of 40-50%, with half maximal effective concentrations of 1.1 microM (MRT67307), 5 microM (BX-795) and 24.8 microM (amlexanox)."
34119434